Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Morphotek®, Inc., a subsidiary of Eisai Inc., has announced the launch of its Antibody Drug Conjugate (ADC) Services business based on its proprietary REsidue-SPEcific Conjugation TechnologyTM (RESPECTTM) and eribulin-linker toxin platforms.
read more
Abbott announced the FDA has issued Emergency Use Authorization for the company's molecular test for novel coronavirus.
read more
Monday, February 04, 2019
Lambda Therapeutic Research has reached an agreement to acquire Novum Pharmaceutical Research Services, a CRO in the U.S., in a private transaction. Terms were not disclosed.
read more
Monday, September 07, 2020
PAI announced the company has been awarded a three-year contract from HealthTrust Purchasing Group as a supplier of pharmaceutical products to its Membership nationwide.
read more
Wednesday, January 13, 2021
Abzena has announced the addition of a 6th Global site that will augment cGMP manufacturing capacity for mammalian biologics.
read more
Wednesday, August 02, 2023
Syneos Health announced that the company’s stockholders approved an agreement to take the company private through an acquisition by a consortium of private investment firm affiliates comprised of Elliott Investment Management L.P., Patient Square ...
read more
Friday, February 14, 2020
Thermo Fisher Scientific and NanoPin have entered into a collaborative relationship to advance blood-based infectious disease detection technology through the development of highly sensitive LC-MS-based workflows.
read more
Thursday, January 05, 2023
Verrica Pharmaceuticals Inc. announced the successful completion of the technology transfer of bulk solution manufacturing to Piramal Pharma Solutions.
read more
Tuesday, February 06, 2024
Catawba Research, a global clinical research organization (CRO), announced a new collaboration with Bingli Inc., which provides AI-guided diagnosis, disease management, and navigation for patients and healthcare providers.
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, ...
read more
Thursday, January 02, 2025
GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the number of GMP-grade iPS cells manufactured has reached 100 lines.
read more
Dalton Pharma Services has successfully received a ‘Compliant’ rating from the Health Products and Food Branch Inspectorate of Health Canada.
read more
United Therapeutics announced the closing of the transactions contemplated by its license agreement with Arena Pharmaceuticals.
read more
Tuesday, February 02, 2021
Raremark has named Caroline O’Connor as its new Chief Commercial Officer to drive the business forward.
read more
AIT Laboratories (AIT) announces the appointment of R. Matthew Neff as President and Chief Executive Officer of the company, effective August 5, 2013. Neff will also remain in his role as Chairman of the Board for the company. Dr. Michael Evans, the...
read more